Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript February 8, 2023
Operator: Welcome to the Teva’s Fourth Quarter and Full Year 2022 Earnings Call. Please be advised that this conference is being recorded. I would now like to hand the conference over to our first speaker today, Ran Meir, Senior Vice President, Head of Investor Relations. Please go ahead.
Ran Meir: Thank you, Nadia. Thank you, everyone, for joining us today. We hope you have had an...
